08Mar 2018

FACTEURS DE RISQUES SOCIODEMOGRAPHIQUES DU SYNDROME METABOLIQUE DANS UNE POPULATION DE YAOUNDE-CAMEROUN.

  • D?partement des Sciences Biologiques, Ecole Normale Sup?rieure de l?Universit? de Yaound? I, Yaound?, Cameroun, BP 047.
  • Facult? de M?decine et des Sciences Biom?dicales de l?Universit? de Yaound? I, Yaound?, Cameroun, BP 1364.
  • Centre Hospitalier de Recherche et d?Application de la Chirurgie Endoscopique et de la Reproduction Humaine, Cameroun BP : 5154.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Contexte: Le Syndrome M?tabolique est une constellation d?anomalies m?taboliques qui concourent ? l?augmentation du risque cardiovasculaire chez une personne. Au Cameroun, plusieurs ?tudes relatives au Syndrome M?tabolique existent d?j?, cependant, aucune d?elles ne s?est appesantie sur le syndrome ?tabolique et ses facteurs de risques sociod?mographiques. Notre ?tude se propose d??valuer la pr?valence du Syndrome M?tabolique en fonction des facteurs sociod?mographiques au sein de notre population d??tude puis d?identifier lesquels sont facteurs de risque du syndrome m?tabolique. Mat?riel et M?thodes: Dans le cadre de cette ?tude transversale, nos recherches ont port? sur l??valuation de la pr?valence du Syndrome m?tabolique selon la d?finition de National Cholesterol Education Programm 2001 en fonction des variables sociod?mographiques puis l?identification ses facteurs de risque par r?gression logistique dans une population pr?sum?e saine ayant vivant ? Yaound? recrut?s de Mars 2014 ? D?cembre 2017. R?sultats: A l?issue de notre ?tude, il se d?gage parmi les variables sociod?mographiques ?tudi?es du Syndrome M?tabolique, celles ? risque au sein de notre population sont le sexe f?minin, les tranches d??ge sup?rieures ? 45 ans, la dur?e de r?sidence ? Yaound? sup?rieure ? cinq ans. Les autres variables ? l?instar du statut matrimonial, la zone ?cologique, l?emploi et le niveau d?instruction ne sont pas associ?es au Syndrome M?tabolique. Conclusion: Dans la mise en place des programmes de pr?vention sp?cifiques au Syndrome M?tabolique au sein de nos populations, un accent particulier devra ?tre mis chez les femmes, chez les individus ayant une dur?e de r?sidence en ville de plus de cinq ans et chez les individus ?g?s de plus de 45 ans.

  1. Mensah, G.A. 2003. A heart-healthy and ? stroke-free ? world through policy development, systems change, and environmental supports: a 2020 vision for sub-Saharan Africa. Eth Dis., 13: 4 - 12.
  2. Isomaa, B., Henricsson, M., Almgren, P., Tuomi, T., Taskinen, M.R., Groop, L. 2001. The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. , 44: 1148 - 1154.
  3. Marju Orho-Melander. 2006. Le syndrome m?tabolique : g?n?tique, style de vie et origine ethnique. Diabetes voice, 51: 24 - 26.
  4. Weiss, L.A., Pan, L., Abney, M. 2006. The sex-specific genetic architecture of quantitative traits in humans. Nat Genet., 38: 218 - 222.
  5. Popkin, B.M. 1994. Letter to the Editor Comment: obesity patterns and the nutrition transition in China. Arch Intern Med., 154: 2249 - 2253.
  6. Lebovitz, H.E. 2001. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes., 109 (2): 135 - 148.
  7. Rosmond, R., Bjorntorp, P. 2000. Occupational status, cortisol secretory pattern, and visceral obesity in middle-aged men. Obes Res., 8: 445 - 450.
  8. Genevieve, B., Jordi, S.S., Eul?lia, R., Monica, B., Lluıs S.M. 2008. Sociodemographic risk factors associated with metabolic syndrome in a Mediterranean population. Public Health Nutr., 11(12): 1372 - 1378.
  9. Cameron, A.J, Shaw, J.E., Zimmet, P.Z. 2004. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am., 12: 41 - 64
  10. Eckel, R.H., Grundy, S.M., Zimmet, P.Z. 2005. The metabolic syndrome. Lancet., 365: 1415 - 1428.
  11. UN (United Nations, Dept of Economic and Social Information and Policy Analysis). (1993). World urbanization prospects: the 1992 revision. 164 p.
  12. Fezeu, L.K., Assah, F.K., Mbanya, D.S., Balkau, B., Kengne, A.P., Awah, P.K., Mbanya, J.C. (2008). Ten-years changes in central obesity and BMI in rural and urban Cameroon. Obesity, 16(5): 1144 - 1147.
  13. (1992b). Conduite de petites enqu?tes nutritionnelles: manuel de terrain. Nutrition et Agriculture n? 5. Rome.
  14. Gornall, A.G., Bardwill, C.J., David, M.M. (1949). Determination of serum proteins by means of the biuret reaction. Biol chem., 177: 752 -766.
  15. Friedwald, W.T., Levy, R.I., Fredrickson, D.S. 1972. Estimation of concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem., 18: 449 ? 502.
  16. Buccolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem, 1974; 19: 476-482.
  17. Warnick GR, Alberers JJ. Heparin-Mn+2 quantification of high density-lipoprotein by ultrafiltration procedure for lipemic samples. Clin Chem, 1978; 24: 900-904.
  18. World Health Organisation(1997b) Obesity Preventing and Managing the global obesity.Obesity: Preventing and managing the Global Epidemic Report of a WHO. Consultation on Obesity, 3-5 June 1997, Geneva, WHO/NUT/NCD/98.1.
  19. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). (2001). Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA., 285: 2486 ? 2497.
  20. Zimmet, P. 2000. Globalization, coca-colonization and the chronic disease epidemic: Can the Doomsday scenario be averted? J Int Med., 247: 301 - 310.
  21. Myoung-Hee, K., Mi-Kyung, K., Youl, B.O., Choi, S., Young-Jeon. 2005. Educational disparities in the metabolic syndrome in a rapidly changing society-the case of South Korea. Int J Epidemiol., 34: 1266 - 1273.
  22. Yumuk, V.D., Hatemi, H., Tarakci, T., Uyar, N., Turan, N., Bagriacik, N., Ipbuker A. 2005. High prevalence of obesity and diabetes mellitus in Konya, a central Anatolian city in Turkey. Diabetes Res Clin Pract., 70: 151 - 158.
  23. Malekzadeh, R., Mohamadnejad, M., Merat, S., Pourshams, A., Etmadi, A. 2005. Obesity pandemic: an Iranian perspective. Arch Iran, 8: 1 - 7.
  24. Yavuz, S.S., Cagatay O., Adnan, H., Mehmet Y., Mehmet, U. 2006. Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey. BMC Public Health., 6: 92 - 103.
  25. Haffner, S.M.1993. Insulin and Blood pressure:fact or fantaisy?Clin. Endocrinol. Metab.,76: 541- 543.
  26. Gu, D., Reynolds, K., Wu, X., Chen, X., Duan, R.F. 2005. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet., 365: 1398 - 1405.
  27. Ko, G.T., Cockram, C.S., Chow, C.C. 2005. High prevalence of metabolic syndrome in Hong Kong Chinese. Comparison of three diagnostic criteria. Diab Res Clin Pract., 69: 160 - 158.
  28. Mbanya, J.C., Minkoulou, E.M., Salah, J.N., Balkau, B. 1998. The prevalence of hypertension in rural and urban Cameroon. Int J Epidemiol., 27(2): 181 - 185.
  29. Fezeu, L.K., Assah, F.K., Mbanya, D.S., Balkau, B., Kengne, A.P., Awah, P.K., Mbanya, J.C. 2008. Ten-years changes in central obesity and BMI in rural and urban Cameroon. Obesity., 16(5): 1144 - 1147.
  30. Davidson, R.G., Kiersten, J., Rohini, P., Adam, V. 2000. For the HNP/Poverty Thematic Group of the World Bank. Socio-economic differences in health, nutrition and population in Cameroon. May.working paper. Vol 1. n? 39467.

[DAMARIS enyegue mandob, messi zac and noa ndoua claude cyrille. (2018); FACTEURS DE RISQUES SOCIODEMOGRAPHIQUES DU SYNDROME METABOLIQUE DANS UNE POPULATION DE YAOUNDE-CAMEROUN. Int. J. of Adv. Res. 6 (Mar). 596-605] (ISSN 2320-5407). www.journalijar.com

Mandob Enyegue Damaris
Department of Biological Sciences, Higher Teachers’ Training College, University of Yaoundé I, Po Box 047, Yaoundé, Cameroon

DOI:

Article DOI: 10.21474/IJAR01/6707      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6707

Download Full Paper

Download PDF No. of Downloads: 69 | No. of Views: 324